Search results
12 recent scientific breakthroughs
The Week via Yahoo News· 4 days agoBut that doesn't mean they weren't still busy researching a dizzying series of developments that are now being reported as major discoveries and...
Covid-19 Pharma Stars Continue Their Quest To Set New Standards In Cancer Treatment
Benzinga via Yahoo Finance· 5 days agoIts pharma peer, BioNTech SE (NASDAQ: BNTX) wasn’t as lucky as also on Monday, the FDA put its...
Gateway - The Root
The Root· 4 days agoHealth experts in Mississippi and the federal level are urging residents in the state not to ingest ivermectin to treat COVID-19. In case you wanna know ...
COVID summer wave grows, with new variant LB.1 on the rise
WLTX-TV Columbia· 1 day agoA summertime wave of COVID-19 infections is arriving earlier than last year across a growing share...
A Synergy Of Excellence: Novavax-Mabion Partnership During Unprecedented Times Amid The Covid-19...
BioresearchOnline· 3 days agoNovavax's COVID-19 vaccine, Nuvaxovid, was developed in record time with the support of Mabion, a...
New York midwife pleads guilty to destroying 2,600 COVID-19 vaccines and issuing fraudulent cards
Associated Press· 5 days agoAn upstate New York midwife pleaded guilty on Monday to federal fraud charges for her role in giving...
Kansas Sues Pfizer Over Covid-19 Vaccine’s Safety, Efficacy
Bloomberg Law· 5 days agoThe lawsuit was filed by state Attorney General Kris Kobach in Kansas District Court, Thomas County. Pfizer said its vaccine would prevent the transmission of Covid-
Did FDA rule change allowing gay, bisexual men to donate blood make a difference? Some early data...
Good Morning America via Yahoo News· 5 days agoFor years, Jose Dominguez, 50, had wanted to donate blood, feeling it was part of his civic duty. In...
BioNTech Cancer Drug Licensed From MediLink Faces FDA Delay
Bloomberg via Yahoo Finance· 5 days ago(Bloomberg) -- The Food and Drug Administration delayed a breast- and lung-cancer trial of an...
Gateway - Quartz
Quartz· 5 days agoMeanwhile, Pfizer announced Wednesday another cost-cutting initiative as the company struggles with diminishing demand for its COVID-19 vaccine. A U.S.